UCSF Researchers Pinpoint Molecule That Triggers Deadly Progress Of Pulmonary Fibrosis

Scientists have uncovered crucial steps in a grim molecular dance that asphyxiates more than 5,000 people a year in the United States. The research pinpoints a pivotal protein involved in a multi-step process leading to pulmonary fibrosis, an incurable lung inflammation that eventually robs the lungs of their ability to supply oxygen to the blood.

The protein's specific and localized role makes it a prime target for developing a drug to block the severe lung scarring caused by the condition, the scientists conclude.

The research, reported in the February 5 issue of the journal Cell, was led by Dean Sheppard, MD, professor of medicine at the University of California San Francisco (UCSF) and director of the UCSF Lung Biology Center at San Francisco General Hospital Medical Center.

It has been known for more than a decade that a molecule known as TGF Beta plays an essential role in healing damaged tissue throughout the body. The molecule is active too in the debilitating buildup of excessive fibrous scar tissue in the lungs. The difference between restorative scarring and uncontrolled, deadly fibrosis involves the level of activity of TGF Beta, researchers believe.

But what triggers this molecule to develop fibrous tissue in the first place, be it restorative or deadly? Earlier research had concluded that only when enzymes break it down or cut it up, does the TGF Beta protein become active. But working with laboratory cultures of human cells, the UCSF-led research team discovered that a protein called an integrin is essential to activate the TGF Beta molecule, and it accomplishes this neither by breaking down, nor cutting up TGF Beta, but by changing its shape.

Normally part of a larger protein complex, TGF Beta is inactive until it interacts with the alpha v beta 6 integrin, the team found. The integrin lies partly within a cell and partly outside. When it makes contact with the protein complex that includes TGF Beta, it appears to act as

Contact: Wallace Ravven
University of California - San Francisco

Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:

(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. ... with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... supply chain for more than 10 years. Early in the COVID-19 crisis, we ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical ... discover a COVID cure or vaccine, the global economic downturn will only increase price ... not going away and capturing full value from every product launch is critical. However, ...
(Date:7/2/2020)... (PRWEB) , ... July 02, ... ... Biology Systems, B.V. (MBS) has announced a publication detailing the use of ... reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief ... clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an ...
(Date:7/7/2020)... ... , ... Bio-IT World has announced the winners of the ... of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were honored. ... examples of how technology innovations and strategic initiatives can be powerful forces for ...
Breaking Biology Technology:
Cached News: